Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Psychiatry RAISR4D

Adenosine surges: A step forward in understanding antidepressant actions of ketamine

Mol Psychiatry. 2026 Apr 8. doi: 10.1038/s41380-026-03594-4. Online ahead of print.

NO ABSTRACT

PMID:41951836 | DOI:10.1038/s41380-026-03594-4

Document this CPD

Share Evidence Blueprint

QR Code

Search Google Scholar

⭐ My Revision List

RAISR4D-PFD Evidence Matrix

InPsychiatry, RAISR4D

Latest Evidence

Recent Post

Epidemiological Insights into Xenobiotic-Induced Seizures: A Correlational Descriptive Study from a Poisoning Referral Center in Northwestern Iran

Napping during major depressive episodes identifies a distinct hypersomnolence phenotype

Indication-specific adverse event profiles of semaglutide and liraglutide: a FAERS disproportionality analysis

Suicide attempt risk in autism: a national EHR study of 2.3 million individuals

Trauma and “spiritual resilience” among Internally Displaced Women (IDW) victims of violence in the commune of Dédougou, Burkina Faso

Top Category

ChatGPT

Enter your request.

← Identification of an intrusive-hypervigilant phenotype of posttraumatic stress symptoms with unique stress peptide and amygdala functional connectivity profiles ← Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use

← →

RAISR4D CME/CPD Evidence Nodes

Swipe to navigate RAISR4D CME/CPD evidence nodes.

CME/CPD